1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Endometriosis
Therapeutics Market
4. Voice of Customer
5. Executive Summary
6. Clinical Trial Analysis
7.
Global Endometriosis
Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1.
By Endometriosis
Type (Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating
Endometriosis Therapeutics)
7.2.2.
By Diagnostic Method
(Ultrasound, Pelvic Examination, Laparoscopy, Magnetic Resonance Imaging,
Others)
7.2.3.
By Treatment Method
(Hormonal Therapy v/s Pain Management)
7.2.3.1.
By Drug Category
(Oral Contraceptives, Progestins, NSAIDs, GnRH Analogues, Others)
7.2.4.
By Distribution
Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)
7.2.5.
By End User
(Hospitals & Clinics, Ambulatory Care Centers, Others)
7.2.6.
By Region
7.2.7. By
Company (2021)
7.3. Product Market Map
8.
North America
Endometriosis Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1.
By Endometriosis
Type (Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating
Endometriosis Therapeutics)
8.2.2.
By Diagnostic Method
(Ultrasound, Pelvic Examination, Laparoscopy, Magnetic Resonance Imaging,
Others)
8.2.3.
By Treatment Method
(Hormonal Therapy v/s Pain Management)
8.2.3.1.
By Drug Category
(Oral Contraceptives, Progestins, NSAIDs, GnRH Analogues, Others)
8.2.4.
By Distribution
Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)
8.2.5.
By End User
(Hospitals & Clinics, Ambulatory Care Centers, Others)
8.2.6. By
Country
8.3. North America: Country Analysis
8.3.1. United States Endometriosis Therapeutics
Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Endometriosis Type
8.3.1.2.2.
By Diagnostic Method
8.3.1.2.3.
By Therapeutic Method
8.3.1.2.4.
By Distribution Channel
8.3.1.2.5.
By End User
8.3.2. Mexico Endometriosis Therapeutics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Endometriosis Type
8.3.2.2.2.
By Diagnostic Method
8.3.2.2.3.
By Therapeutic Method
8.3.2.2.4.
By Distribution Channel
8.3.2.2.5.
By End User
8.3.3. Canada Endometriosis Therapeutics
Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Endometriosis Type
8.3.3.2.2.
By Diagnostic Method
8.3.3.2.3.
By Therapeutic Method
8.3.3.2.4.
By Distribution Channel
8.3.3.2.5.
By End User
9.
Europe Endometriosis
Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1.
By Endometriosis
Type (Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating
Endometriosis Therapeutics)
9.2.2.
By Diagnostic Method
(Ultrasound, Pelvic Examination, Laparoscopy, Magnetic Resonance Imaging,
Others)
9.2.3.
By Treatment Method
(Hormonal Therapy v/s Pain Management)
9.2.3.1.
By Drug Category
(Oral Contraceptives, Progestins, NSAIDs, GnRH Analogues, Others)
9.2.4.
By Distribution
Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)
9.2.5.
By End User
(Hospitals & Clinics, Ambulatory Care Centers, Others)
9.2.6. By Country
9.3. Europe: Country Analysis
9.3.1. France Endometriosis Therapeutics
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Endometriosis Type
9.3.1.2.2.
By Diagnostic Method
9.3.1.2.3.
By Therapeutic Method
9.3.1.2.4.
By Distribution Channel
9.3.1.2.5.
By End User
9.3.2. United Kingdom Endometriosis Therapeutics
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Endometriosis Type
9.3.2.2.2.
By Diagnostic Method
9.3.2.2.3.
By Therapeutic Method
9.3.2.2.4.
By Distribution Channel
9.3.2.2.5.
By End User
9.3.3. Italy Endometriosis Therapeutics
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Endometriosis Type
9.3.3.2.2.
By Diagnostic Method
9.3.3.2.3.
By Therapeutic Method
9.3.3.2.4.
By Distribution Channel
9.3.3.2.5.
By End User
9.3.4. Germany Endometriosis Therapeutics
Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Endometriosis Type
9.3.4.2.2.
By Diagnostic Method
9.3.4.2.3.
By Therapeutic Method
9.3.4.2.4.
By Distribution Channel
9.3.4.2.5.
By End User
9.3.5. Spain Endometriosis Therapeutics
Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Endometriosis Type
9.3.5.2.2.
By Diagnostic Method
9.3.5.2.3.
By Therapeutic Method
9.3.5.2.4.
By Distribution Channel
9.3.5.2.5.
By End User
10.
Asia-Pacific
Endometriosis Therapeutics Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1. By Endometriosis Type (Superficial Peritoneal
Lesion, Endometrioma, Deeply Infiltrating Endometriosis Therapeutics)
10.2.2. By Diagnostic Method (Ultrasound, Pelvic
Examination, Laparoscopy, Magnetic Resonance Imaging, Others)
10.2.3. By Treatment Method (Hormonal Therapy v/s Pain
Management)
10.2.3.1. By Drug Category (Oral Contraceptives,
Progestins, NSAIDs, GnRH Analogues, Others)
10.2.4. By Distribution Channel (Retail Pharmacies,
Hospital Pharmacies, Online Pharmacies)
10.2.5. By End User (Hospitals & Clinics,
Ambulatory Care Centers, Others)
10.2.6. By Country
10.3.
Asia-Pacific:
Country Analysis
10.3.1. China Endometriosis Therapeutics
Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Endometriosis Type
10.3.1.2.2.
By Diagnostic Method
10.3.1.2.3.
By Therapeutic Method
10.3.1.2.4.
By Distribution Channel
10.3.1.2.5.
By End User
10.3.2. India Endometriosis Therapeutics
Market Outlook
10.3.2.1. Market Size &
Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share &
Forecast
10.3.2.2.1.
By Endometriosis Type
10.3.2.2.2.
By Diagnostic Method
10.3.2.2.3.
By Therapeutic Method
10.3.2.2.4.
By Distribution Channel
10.3.2.2.5.
By End User
10.3.3. Japan Endometriosis Therapeutics Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share &
Forecast
10.3.3.2.1.
By Endometriosis Type
10.3.3.2.2.
By Diagnostic Method
10.3.3.2.3.
By Therapeutic Method
10.3.3.2.4.
By Distribution Channel
10.3.3.2.5.
By End User
10.3.4. South Korea Endometriosis Therapeutics
Market Outlook
10.3.4.1. Market Size &
Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market Share &
Forecast
10.3.4.2.1.
By Endometriosis Type
10.3.4.2.2.
By Diagnostic Method
10.3.4.2.3.
By Therapeutic Method
10.3.4.2.4.
By Distribution Channel
10.3.4.2.5.
By End User
10.3.5. Australia Endometriosis Therapeutics
Market Outlook
10.3.5.1. Market Size &
Forecast
10.3.5.1.1.
By Value
10.3.5.2. Market Share &
Forecast
10.3.5.2.1.
By Endometriosis Type
10.3.5.2.2.
By Diagnostic Method
10.3.5.2.3.
By Therapeutic Method
10.3.5.2.4.
By Distribution Channel
10.3.5.2.5.
By End User
11.
South America
Endometriosis Therapeutics Market Outlook
11.1.
Market Size &
Forecast
11.1.1. By Value
11.2.
Market Share &
Forecast
11.2.1. By Endometriosis Type (Superficial Peritoneal Lesion,
Endometrioma, Deeply Infiltrating Endometriosis Therapeutics)
11.2.2. By Diagnostic Method (Ultrasound, Pelvic
Examination, Laparoscopy, Magnetic Resonance Imaging, Others)
11.2.3. By Treatment Method (Hormonal Therapy v/s Pain
Management)
11.2.3.1.
By Drug Category (Oral
Contraceptives, Progestins, NSAIDs, GnRH Analogues, Others)
11.2.4. By Distribution Channel (Retail Pharmacies,
Hospital Pharmacies, Online Pharmacies)
11.2.5. By End User (Hospitals & Clinics,
Ambulatory Care Centers, Others)
11.2.6. By Country
11.3.
South America:
Country Analysis
11.3.1. Brazil Endometriosis Therapeutics
Market Outlook
11.3.1.1. Market Size &
Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share &
Forecast
11.3.1.2.1.
By Endometriosis Type
11.3.1.2.2.
By Diagnostic Method
11.3.1.2.3.
By Therapeutic Method
11.3.1.2.4.
By Distribution Channel
11.3.1.2.5.
By End User
11.3.2. Argentina Endometriosis Therapeutics
Market Outlook
11.3.2.1. Market Size &
Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share &
Forecast
11.3.2.2.1.
By Endometriosis Type
11.3.2.2.2.
By Diagnostic Method
11.3.2.2.3.
By Therapeutic Method
11.3.2.2.4.
By Distribution Channel
11.3.2.2.5.
By End User
11.3.3. Colombia Endometriosis Therapeutics
Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share &
Forecast
11.3.3.2.1.
By Endometriosis Type
11.3.3.2.2.
By Diagnostic Method
11.3.3.2.3.
By Therapeutic Method
11.3.3.2.4.
By Distribution Channel
11.3.3.2.5.
By End User
12.
Middle East and
Africa Endometriosis Therapeutics Market Outlook
12.1.
Market Size &
Forecast
12.1.1. By Value
12.2.
Market Share &
Forecast
12.2.1. By Endometriosis Type (Superficial Peritoneal
Lesion, Endometrioma, Deeply Infiltrating Endometriosis Therapeutics)
12.2.2. By Diagnostic Method (Ultrasound, Pelvic
Examination, Laparoscopy, Magnetic Resonance Imaging, Others)
12.2.3. By Treatment Method (Hormonal Therapy v/s Pain
Management)
12.2.3.1.
By Drug Category
(Oral Contraceptives, Progestins, NSAIDs, GnRH Analogues, Others)
12.2.4. By Distribution Channel (Retail Pharmacies,
Hospital Pharmacies, Online Pharmacies)
12.2.5. By End User (Hospitals & Clinics, Ambulatory
Care Centers, Others)
12.2.6. By Country
12.3.
MEA: Country
Analysis
12.3.1. South Africa Endometriosis Therapeutics
Market Outlook
12.3.1.1. Market Size &
Forecast
12.3.1.1.1.
By Value
12.3.1.2. Market Share &
Forecast
12.3.1.2.1.
By Endometriosis Type
12.3.1.2.2.
By Diagnostic Method
12.3.1.2.3.
By Therapeutic Method
12.3.1.2.4.
By Distribution Channel
12.3.1.2.5.
By End User
12.3.2. UAE Endometriosis Therapeutics
Market Outlook
12.3.2.1. Market Size &
Forecast
12.3.2.1.1.
By Value
12.3.2.2. Market Share &
Forecast
12.3.2.2.1.
By Endometriosis Type
12.3.2.2.2.
By Diagnostic Method
12.3.2.2.3.
By Therapeutic Method
12.3.2.2.4.
By Distribution Channel
12.3.2.2.5.
By End User
12.3.3. Saudi Arabia Endometriosis Therapeutics
Market Outlook
12.3.3.1. Market Size &
Forecast
12.3.3.1.1.
By Value
12.3.3.2. Market Share &
Forecast
12.3.3.2.1.
By Endometriosis Type
12.3.3.2.2.
By Diagnostic Method
12.3.3.2.3.
By Therapeutic Method
12.3.3.2.4.
By Distribution Channel
12.3.3.2.5.
By End User
12.3.4. Egypt Endometriosis Therapeutics
Market Outlook
12.3.4.1. Market Size &
Forecast
12.3.4.1.1.
By Value
12.3.4.2. Market Share &
Forecast
12.3.4.2.1.
By Endometriosis Type
12.3.4.2.2.
By Diagnostic Method
12.3.4.2.3.
By Therapeutic Method
12.3.4.2.4.
By Distribution Channel
12.3.4.2.5.
By End User
12.3.5. Turkey Endometriosis Therapeutics
Market Outlook
12.3.5.1. Market Size &
Forecast
12.3.5.1.1.
By Value
12.3.5.2. Market Share & Forecast
12.3.5.2.1.
By Endometriosis Type
12.3.5.2.2.
By Diagnostic Method
12.3.5.2.3.
By Therapeutic Method
12.3.5.2.4.
By Distribution Channel
12.3.5.2.5.
By End User
13. Market Dynamics
13.1.
Drivers
13.2.
Challenges
14. Market Trends & Developments
15. Competitive Landscape
15.1.
Abbott Laboratories,
Inc.
15.2.
AbbVie, Inc.
15.3.
Bayer AG
15.4.
Pfizer, Inc.
15.5.
Ipsen SA
15.6.
Evotec SE
15.7.
Myovant Sciences
Ltd.
15.8.
Philogen S.p.A.
15.9.
Astellas Pharma Inc.
15.10.
Orphagen
Pharmaceuticals, Inc.
16. Strategic Recommendations